Components:
Medically reviewed by Kovalenko Svetlana Olegovna, PharmD. Last updated on 26.06.2023

Attention! Information on this page is intended only for medical professionals! Information is collected in open sources and may contain significant errors! Be careful and double-check all the information on this page!
Methocarbamol (Robaxifen) tablets USP are indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. The mode of action of Methocarbamol (Robaxifen) has not been clearly identified, but may be related to its sedative properties. Methocarbamol (Robaxifen) does not directly relax tense skeletal muscles in man.
Adult & child over 12 yrs: 1-2 tabs tid; child under 12 yrs: not recommended.
Methocarbamol (Robaxifen) tablets USP are contraindicated in patients hypersensitive to Methocarbamol (Robaxifen) or to any of the tablet components.
Acetaminophen is metabolized (eliminated by conversion to other chemicals) by the liver. Therefore drugs that increase the action of liver enzymes that metabolize acetaminophen [for example, carbamazepine (Tegretol), isoniazid (INH, Nydrazid, Laniazid), rifampin (Rifamate, Rifadin, Rimactane)] reduce the levels of acetaminophen and may decrease the action of acetaminophen. Doses of acetaminophen greater than the recommended doses are toxic to the liver and may result in severe liver damage. The potential for acetaminophen to harm the liver is increased when it is combined with alcohol or drugs that also harm the liver.
Cholestyramine (Questran) reduces the effect of acetaminophen by decreasing its absorption into the body from the intestine. Therefore, acetaminophen should be administered 3 to 4 hours after cholestyramine or one hour before cholestyramine.
Acetaminophen doses greater than 2275 mg per day may increase the blood thinning effect of warfarin (Coumadin) by an unknown mechanism. Therefore, prolonged administration or large doses of acetaminophen should be avoided during warfarin therapy
Stomach upset, nausea, flushing, constipation, headache, blurred vision, lightheadedness, dizziness or drowsiness may occur during the first few days as your body adjusts to this medication. If these symptoms persist or become severe, notify your doctor or pharmacist promptly. Tell your doctor immediately if any of these unlikely but serious side effects occur: fast/slow heartbeat, fainting, yellowing eyes or skin, persistent nausea/vomiting, stomach/abdominal pain, mental/mood changes, clumsiness, trouble urinating, signs of infection (e.g., persistent sore throat, fever). This medication may cause your urine to turn green-black in color. This harmless effect is temporary and will disappear when the medication is stopped. A serious allergic reaction to this drug is unlikely, but seek immediate medical attention if it occurs. Symptoms of a serious allergic reaction include: rash, itching, swelling, severe dizziness, trouble breathing. If you notice other effects not listed above, contact your doctor or pharmacist.